Drug General Information (ID: DDIFC1IPH9)
  Drug Name Rofecoxib Drug Info Captopril Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antiinflammatory Agents Antihypertensive Agents
  Structure

 Mechanism of Rofecoxib-Captopril Interaction (Severity Level: Moderate)
     Antagonize the effect of antihypertensive agents Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Rofecoxib Captopril
      Mechanism 1 Hypertensive effects Antihypertensive agent
      Key Mechanism Factor 1
Factor Name Antihypertensive agents
Factor Description The hypotensive effect of antihypertensive agents may be reduced, leading to higher blood pressure, increased blood pressure fluctuations, and possible cardiovascular damage.
      Mechanism Description
  • Antagonize the effect of Captopril when combined with Rofecoxib 
      Mechanism 2 Hypertensive effects Hypotensive effects
      Key Mechanism Factor 2
Factor Name Antihypertensive agents
Factor Description The hypotensive effect of antihypertensive agents may be reduced, leading to higher blood pressure, increased blood pressure fluctuations, and possible cardiovascular damage.
      Mechanism Description
  • Antagonize the effect of Captopril when combined with Rofecoxib 

Recommended Action
      Management Patients receiving ACE inhibitors who require prolonged (greater than 1 week) concomitant therapy with an NSAID should have blood pressure monitored more closely following initiation, discontinuation, or change of dosage of the NSAID. Renal function should also be evaluated periodically during prolonged coadministration. The interaction is not expected to occur with low doses (e.g., low-dose aspirin) or intermittent short-term administration of NSAIDs.

References
1 Abdel-Haq B, Magagna A, Favilla S, Salvetti A "Hemodynamic and humoral interactions between perindopril and indomethacin in essential hypertensive subjects." J Cardiovasc Pharmacol 18 (1991): s33-6. [PMID: 1725198]
2 Ahmad S "Indomethacin-enalapril interaction: an alert." South Med J 84 (1991): 411-2. [PMID: 2000541]
3 Allon M, Pasque CB, Rodriguez M "Interaction of captopril and ibuprofen on glomerular and tubular function in humans." Am J Physiol 259 (1990): f233-8. [PMID: 2201204]
4 Moore TJ, Crantz FR, Hollenberg NK "Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension." Hypertension 3 (1981): 168-73. [PMID: 6260645]
5 Morgan T, Anderson A "Interaction of indomethacin with felodipine and enalapril." J Hypertens 11 (1993): S338-9. [PMID: 8158412]
6 Product Information. Celebrex (celecoxib). Searle, Chicago, IL.
7 Product Information. Daypro (oxaprozin). Searle, Skokie, IL.
8 Product Information. Toradol (ketorolac). Roche Laboratories, Nutley, NJ.
9 Radack KL, Deck CC, Bloomfield SS "Ibuprofen interferes with the efficacy of antihypertensive drugs: a randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen." Ann Intern Med 107 (1987): 628-35. [PMID: 2889416]
10 Seto S, Aoi W, Iwami K, et al "Effect of propranolol and indomethacin on the depressor action of captopril in patients with essential hypertension." Clin Exp Hypertens 9 (1987): 623-7. [PMID: 3301085]
11 Silberbauer K, Stanek B, Templ H "Acute hypotensive effect of captopril in man modified by prostaglandin synthesis inhibition." Br J Clin Pharmacol 14 (1982): s87-93. [PMID: 6753910]
12 Townend JN, Doran J, Lote CJ, Davies MK "Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril." Br Heart J 73 (1995): 434-41. [PMID: 7786658]
13 Polonia J, Boaventura I, Gama G, Camoes I, Bernardo F, Andrade P, Nunes JP, Brandao F, Cerqueiragomes M "Influence of non-steroidal anti-inflammatory drugs on renal function and 24h ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients." J Hypertens 13 (1995): 925-31. [PMID: 8557971]